***** TODAY’S NEWS What about those bone fracture risks with biophosphonate drugs? The jury is still out - A new study gives reassuring news about the safety of Fosamax and Reclast, bone-building …
Today’s Top Three in Pharma 060109
Novartis' Reclast gets approval for osteoporosis prevention in post-menopausal women - Reclast® (zoledronic acid 5 mg) Injection[*] has been approved by the US Food and Drug Administration (FDA) as …